Inventor
FORD ANTHONY P
US19 patents
⚠️ This page may combine multiple inventors who share the name “FORD ANTHONY P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AFFERENT PHARMACEUTICALS INC
13 patentsUS9284279B2Mar 15, 2016
Substituted pyrimidines for treatment of acute cough, chronic cough and urge to cough
AFFERENT PHARMACEUTICALS INC13 citations80
US10822311B2Nov 3, 2020
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC3 citations71
US10662162B2May 26, 2020
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC2 citations71
US10206922B2Feb 19, 2019
Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough
AFFERENT PHARMACEUTICALS INC2 citations69
US9724346B2Aug 8, 2017
Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough
AFFERENT PHARMACEUTICALS INC2 citations69
US10195198B2Feb 5, 2019
Methods and compositions for treating diseases and conditions
AFFERENT PHARMACEUTICALS INC2 citations68
US11230533B2Jan 25, 2022
Crystalline salts and polymorphs of a P2X3 antagonist
AFFERENT PHARMACEUTICALS INC0 citations62
US10676444B2Jun 9, 2020
Crystalline salts and polymorphs of a P2X3 antagonist
AFFERENT PHARMACEUTICALS INC1 citations62
US11591315B2Feb 28, 2023
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
AFFERENT PHARMACEUTICALS INC0 citations60
US11230532B2Jan 25, 2022
Pyrimidines and variants thereof, and uses therefor
AFFERENT PHARMACEUTICALS INC0 citations60
US10988460B2Apr 27, 2021
Substituted pyrazole-pyrimidines, variants thereof, and uses therefore
AFFERENT PHARMACEUTICALS INC0 citations60
US10543211B2Jan 28, 2020
Methods and compositions for treating diseases and conditions
AFFERENT PHARMACEUTICALS INC1 citations57
US11260056B2Mar 1, 2022
Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of cough
AFFERENT PHARMACEUTICALS INC0 citations52
CURASEN THERAPEUTICS INC
6 patentsUS11040944B2Jun 22, 2021
Beta adrenergic agonist and methods of using the same
CURASEN THERAPEUTICS INC1 citations72
US10947196B2Mar 16, 2021
Beta adrenergic agonist and methods of using the same
CURASEN THERAPEUTICS INC2 citations72
US11607395B2Mar 21, 2023
Methods for improving neurological diseases and disorders
CURASEN THERAPEUTICS INC4 citations70
US12448352B2Oct 21, 2025
Beta adrenergic agonist and methods of using the same
CURASEN THERAPEUTICS INC0 citations61
US11590107B2Feb 28, 2023
Methods for treating neurological disorders with α1A-AR partial agonists
CURASEN THERAPEUTICS INC1 citations61
US12558325B2Feb 24, 2026
Methods for improving neurological diseases and disorders
CURASEN THERAPEUTICS INC0 citations58